A single dose of Rivaroxaban 20&#45

2 trials

Sponsors

Novartis (Thailand) Ltd.

Conditions

Healthy volunteers Healthy volunteers Bioequivalence Rivaroxaban Pharmacokinetic study

Phase 1

A Bioequivalence Study of Two Formulations of 20-mg Rivaroxaban Tablets in Healthy Thai Volunteers under Fed Condition

Active, not recruitingTCTR20190503001

Novartis (Thailand) Ltd.Healthy volunteers Healthy volunteers Bioequivalence Rivaroxaban Pharmacokinetic study

Start: 2019-08-06Target: 24Updated: 2026-08-03

A Bioequivalence Study of Two Formulations of 20-mg Rivaroxaban Tablets in Healthy Thai Volunteers under Fed Condition

Active, not recruitingTCTR20200513006

Novartis (Thailand) Ltd.Healthy volunteers Healthy volunteers Bioequivalence Rivaroxaban Pharmacokinetic study

Start: 2020-08-25Target: 40Updated: 2026-08-03